The Funding of Biopharmaceutical Research and Development
The funding of biopharmaceutical research and development provides a comprehensive critical review of the funding of research and development (R&D) in the human biopharmaceutical market sector. It addresses both private and public funding sources available in the US and internationally. The biopharmaceutical market is among the most research-intensive market sectors globally. Clinical researchers face a multitude of public and private funding options with respect to bringing their idea or innovation to market. These funding options are continually changing and complex, and are expected to decrease in the near future. A lack of understanding of the scale, scope, and inner workings of the funding aspects of R&D can, at times, act as a barrier for all involved, and can slow down or even eliminate the R&D process. The book lessens these barriers by describing the theoretical underpinnings, present practice, and trends in R&D funding in this market sector, both in the US and internationally. This includes a review and discussion of public-private partnership activity and their inner-workings, noting the complementary relationship between public and private funding. The book also contains an overview of the inner-workings of strategic alliance activity, including the advantages and disadvantages for each party. It goes on to provide an outline of venture capital activity, detailing the methods by which venture capital firms raise capital and are organized, a description of the venture capital-entrepreneur arrangement, and the effects of this arrangement. The book also presents an overview of the IPO process and the various fates of firms going public.View full description
Researchers (clinical and non-clinical) and practitioners in the biopharmaceutical market sector in R&D funding processes; Graduate students in health sciences and MBA programs interested in biopharmaceutical funding issues
- Published: October 2013
- Imprint: Woodhead Publishing
- ISBN: 978-1-907568-94-7
Table of ContentsIntroduction to the biopharmaceutical market; Synopsis of theories of the firm and valuation methods; Innovation and the merging of the pharmaceutical and biotechnology industries; The funding of basic research and public-private partnerships; Strategic alliances; Angel and venture capital; The initial public offering; Conclusion.